Načítá se...
The Intersection of Diabetes and Cardiovascular Disease—A Focus on New Therapies
Diabetes is a leading cause of cardiovascular disease and its associated morbidity. While the medical community has had access to numerous glucose lowering therapies over the last decades, it was not until recently that newer agents demonstrated improvement in cardiovascular outcomes. In particular,...
Uloženo v:
| Vydáno v: | Front Cardiovasc Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282028/ https://ncbi.nlm.nih.gov/pubmed/30555833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2018.00160 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|